Skip to main content

Gennev is covered by insurance companies. Check if you are in network now.

Neurokinin receptor antagonists represent a new frontier in managing vasomotor symptoms, but many clinicians are still navigating their role in practice. We will review the underlying physiology, summarize available safety and efficacy data, compare agents, and address insurance and access challenges. We’ll also walk through practical prescribing considerations.


We’ll discuss these topics and take your questions in this 60-minute webinar.